StockData
BioMarin Pharmaceutical Inc logo

BioMarin Pharmaceutical Inc (BMRN) stock

BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3093% above fair value
$58.51+0.52 (+0.90%)

Close on Nov 17, 2026Market cap $11.33BP/E 154.0Yield –

BioMarin Pharmaceutical total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioMarin Pharmaceutical's total debt was $4.19B at Jun 30, 2026. For fiscal 2025 it was $597.18M.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$597.18M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.19B–
Q4 FY2025Dec 31, 2025$597.18M–

More BioMarin Pharmaceutical figures

See a number that looks wrong?